Biotech Values

[drugrunner]

dew diligence/ i was reading your post to FOTD, answering his questions regarding statistics /HR etc for GNVC's drug TNFERADE. ..

and you summarize by saying .. nothing in the data makes you interested in the stock..

what is your justification for saying that.. considering that your answers to FOTD surmise the drugs works just fine for about 20-40% of the patients dosed.. which is very similar to most every other chemo drug on the market..

especially considering that this specific diagnosis is a guaranteed death sentence..

the CI is barely over the threshold of 1.00. actually 1.15..

data from the next peak at 184 events should yield stat sig if the data holds this line of efficacy

druggie